A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.

about

Human Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Atopic Dermatitis by Regulating the Expression of MIP-2, miR-122a-SOCS1 Axis, and Th1/Th2 Responses

P2860

Q59128355-DFB75AA7-0BF6-4999-942A-CAEBB76BB2F1

P2860

A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.

Item

http://www.wikidata.org/entity/Q55048045

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@en

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@nl

type

Item

label

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@en

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@nl

prefLabel

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@en

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@nl

P1476

A Novel Catecholopyrimidine Ba ...... tory Cytokines in Atopic Mice.

@en

P2093

Baskaran Purushothaman

http://www.w3.org/2001/XMLSchema#string

Joon Myong Song

http://www.w3.org/2001/XMLSchema#string

Parthasarathy Arumugam

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis

Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis

Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model

P304

485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00485

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29867490

http://www.w3.org/2001/XMLSchema#string

P932

5958743

http://www.w3.org/2001/XMLSchema#string

A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.

about

P2860

P2860

A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932